We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Italy to resume use of AstraZeneca jab from Friday - PM Draghi

Thu, 18th Mar 2021 17:16

ROME, March 18 (Reuters) - Italy will resume using the
AstraZeneca COVID-19 vaccine from Friday, Prime Minister Mario
Draghi said, following a report by the European Medicines Agency
which judged that its benefits outweighed risks.

Italy was among a dozen countries that had suspended the use
of the vaccine earlier this week after reports of rare blood
disorders in a handful of people who had recently received a
jab.

"The government's priority remains to vaccinate as many
people as possible as quickly as possible," Draghi said in a
brief statement.
(Reporting By Gavin Jones, editing by Crispian Balmer)

Related Shares

More News
Today 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump...

Today 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth readi...

Today 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover ta...

Today 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln *

Today 09:18

TOP NEWS: AstraZeneca upbeat as cancer drugs underpin sales growth

(Alliance News) - AstraZeneca PLC on Thursday hailed the potential of its drugs pipeline as it delivered impressive growth in sales and profit in the ...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.